Ming Lei

7.6k citations
61 papers · 1.2k indexed · 1 hit paper · h-index 20

Ming Lei

56 papers receiving 1.2k citations

Hit Papers

Nivolumab plus low-dose ipilimumab in previously treated ...154202220262023202450100150

Peers

Ming Lei
Comparison fields: 5 of 108
  • Oncology 456
  • Cancer Research 205
  • Gastroenterology 71
  • Pulmonary and Respiratory Medicine 288
  • Pathology and Forensic Medicine 153
Replace Zhongxin Li with:
Zhongxin Li China
Wei An China
Yongsheng Zhang China
Xiaohua Wang China
Agnieszka Paziewska Poland
Ziwei Wang China
Ying Lv China
Yingjie Li China
Cristian Loretelli Italy
Dipak Panigrahy United States
Ming Lei relative to Zhongxin Li China Zhongxin Li's profile →
Citations per field
00.5×2.7×
Zhongxin Li · 1×
Citations per year

Countries citing papers authored by Ming Lei

Since Specialization
Citations

This map shows the geographic impact of Ming Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Lei more than expected).

Fields of papers citing papers by Ming Lei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Lei. The network helps show where Ming Lei may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ming Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ming Lei Line = papers co-authored together Ming Lei links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 202427
3 20235
4 202319
5 20234
6 202211
7 202210
8 20226
9 202211
10 202212
11 202116
12 20215
13 20217
14 20215
15 202120
16 202125
17 202046
18 2020139
19
Meniscus Allograft Transplantation for Discoid Lateral Meniscus: Clinical Comparison Between Discoid Lateral Meniscus and Nondiscoid Lateral Meniscus
20199
20 201433

About Ming Lei

Ming Lei is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 61 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (17 papers), Esophageal Cancer Research and Treatment (9 papers), Gastric Cancer Management and Outcomes (8 papers), Cancer-related molecular mechanisms research (7 papers), MicroRNA in disease regulation (5 papers), Genetic factors in colorectal cancer (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Cervical Cancer and HPV Research (4 papers). The work is most often cited by research in Oncology (456 citations), Cancer Research (205 citations) and Gastroenterology (71 citations). Ming Lei has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Fei Zhao, Weiwei Huang, Zhen Wang, Kun Xiong, Eric Van Cutsem, Jaffer A. Ajani, Markus Moehler, Yangyang Han, Thierry André and Kaoru Kondo. Their work appears in journals such as Journal of Clinical Oncology, The Journal of Immunology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026